Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome
JACC · 2026-08
DOI: 10.1016/j.jacc.2026.08.026 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JACC, 2026-08. Verfasst von Kazuma Oyama und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novartis Pharma AG.
Abstract (Originalsprache)
BACKGROUND: Although guideline-recommended intensive lipid-lowering therapy (LLT) reduces recurrent cardiovascular events after acute coronary syndrome (ACS), timely implementation of intensive LLT and achievement of low-density lipoprotein cholesterol (LDL-C) target remain suboptimal in routine clinical practice. OBJECTIVES: The purpose of this study was to determine whether a protocol-based implementation strategy improves timely achievement of guideline-recommended LDL-C target after ACS. METHODS: We conducted a cluster-randomized trial involving patients with ACS. Ten centers were randomly assigned 1:1 to protocol-based or standard lipid management. In the protocol-based group, LLT was initiated or intensified during the index hospitalization according to a prespecified algorithm based on baseline LLT status and LDL-C levels using high-intensity statins, ezetimibe, and PCSK9 inhibitors. LDL-C was reassessed at 4 weeks, with treatment escalation when indicated. In the protocol-based group, an LDL-C level of approximately 55 mg/dL was used as the protocol-specified operational threshold for intensification, whereas LDL-C
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Biostatistics, JORTC Data Center, Tokyo, Japan.
- Cardiovascular Division, Hiraka General Hospital, Yokote, Japan.
- Department of Cardiology, Iwate Prefectural Central Hospital, Morioka, Japan.
- Department of Cardiology, Iwate Prefectural Isawa Hospital, Oshu, Japan.
- Department of Cardiology, Kesennuma City Hospital, Kesennuma, Japan.
Förderung
- Novartis Pharma AG
Zitieren
APA
Oyama, K., Takahashi, J., Funaki, T., Oyamada, S., Horiguchi, S., Nakamura, A., Yagi, T., Ogata, K., Yahagi, H., Iwabuchi, K., Namiuchi, S., Tomioka, T., Sugi, M., Yasuda, S., & BRIDGE Investigators (2026). Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome. JACC. https://doi.org/10.1016/j.jacc.2026.08.026
Vancouver
Oyama K, Takahashi J, Funaki T, Oyamada S, Horiguchi S, Nakamura A, et al. Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome. JACC. 2026. doi:10.1016/j.jacc.2026.08.026
BibTeX
@article{Oyama2026,
author = {Oyama, Kazuma and Takahashi, Jun and Funaki, Takahiro and Oyamada, Shunsuke and Horiguchi, Satoru and Nakamura, Akihiro and Yagi, Takuya and Ogata, Kazunori and Yahagi, Hirokazu and Iwabuchi, Kaoru and Namiuchi, Shigeto and Tomioka, Tomoko and Sugi, Masafumi and Yasuda, Satoshi and BRIDGE Investigators, BRIDGE Investigators},
title = {Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome},
journal = {JACC},
year = {2026},
doi = {10.1016/j.jacc.2026.08.026}
}
EUVIMED